Mortality in intensive care: The impact of bacteremia and the utility of systemic inflammatory response syndrome. American Journal of Infection Control, 44(11), pp. 1291Control, 44(11), pp. -1295Control, 44(11), pp. . (doi:10.1016Control, 44(11), pp. /j.ajic.2016 This is the author's final accepted version.There may be differences between this version and the published version. You are advised to consult the publisher's version if you wish to cite from it.
TitleMortality in intensive care -the impact of bacteremia and the utility of SIRS.
2
Abstract
ObjectiveTo determine the impact of bacteraemia on ICU mortality and develop a bacteremia prediction tool using Systemic Inflammatory Response Syndrome (SIRS) criteria.
ParticipantsPatients aged >18 who had blood cultures taken in the ICU 1 st January 2011-31 st December 2013.
DesignAll patients meeting the above criteria were identified from microbiology department records of Glasgow Royal Infirmary, Scotland. Clinical and outcome data were gathered from ICU records. Patients with clinically significant bacteraemia were matched to controls using propensity scores. SIRS criteria were gathered and used to create decision rules to predict the absence of bacteraemia.
Main outcome measuresMortality at ICU discharge. Sensitivity and accuracy of prediction of blood culture status by SIRS decision rule.
ResultsOne hundred patients had a clinically significant positive blood culture and were matched to 100 controls. Bacteraemic patients had higher ICU mortality (OR 2.35 p=0.001) and longer ICU stay (17.0 vs. 7.8 days, p=<0.001). Of 1548 blood culture episodes, 1274 met ≥2 SIRS criteria (106 significant positive cultures, 1168 negative cultures). There was no association between SIRS criteria and positive blood cultures (p=0.11). A decision rule using three SIRS criteria had optimal predictive performance (sensitivity 56%; specificity 50%) but had low accuracy.
ConclusionICU patients with bacteraemia have increased mortality and length of ICU stay. SIRS criteria cannot be used to identify patients at low risk of bacteraemia.